论文部分内容阅读
目的观察溶栓合剂治疗急性脑梗死的临床疗效,为制定更优的治疗方案提供科学依据。方法以收治的130例急性脑梗死患者为研究对象,对照组给予单纯爱通立治疗,观察组采用爱通立与恩必普溶栓合剂治疗。结果观察组临床治疗总有效率(89.2%)高于对照组(67.7%),差异有统计学意义(P<0.05);观察组神经功能缺损评分(7.8±2.5分)低于对照组的(14.9±4.2分),观察组日常生活能力评价Barthel指数得分(16.2±3.7分)高于对照组的(11.6±3.3分),差异有统计学意义(P<0.05)。结论应用溶栓合剂治疗急性脑梗死可以有效提高临床治疗效果,降低神经功能损伤,提高患者的日常生活能力。
Objective To observe the clinical curative effect of thrombolytic agent in treating acute cerebral infarction and provide scientific basis for making better treatment plan. Methods A total of 130 patients with acute cerebral infarction were enrolled in this study. The control group was treated with Aitongli and the patients in the observation group were treated with Aitongli and Nipu thrombolytic agent. Results The total effective rate (89.2%) in the observation group was higher than that in the control group (67.7%), the difference was statistically significant (P <0.05). The neurological deficit score (7.8 ± 2.5) in the observation group was lower than that in the control group 14.9 ± 4.2). The Barthel index score (16.2 ± 3.7) in the observation group was higher than that in the control group (11.6 ± 3.3), the difference was statistically significant (P <0.05). Conclusion The application of thrombolytic agent in the treatment of acute cerebral infarction can effectively improve the clinical therapeutic effect, reduce the nerve function damage and improve the patients’ daily living ability.